Zebularine showed anti-tumor efficacy in clear cell renal cell carcinoma

BackgroundClear cell renal cell carcinoma (ccRCC) has the highest morbidity among renal cell carcinoma (RCC) subtypes. While existing clinical pharmacological intervention strategies have achieved certain efficacy, challenges including inevitable drug resistance and intricate immune heterogeneity of...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Haoyu Xu, Senlin Peng, Junwu Li, Yuanyuan Bai, Guozhi Zhao, Simin Liang, Wei Tang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Subjects:	clear cell renal cell carcinoma immune-related prognostic index immunological profiling drug screening network pharmacology molecular docking
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1531056/full